Medical Condition

brain tumor

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 3, EARLY_Phase 1

ClinicalMetric tracks all active clinical trials for brain tumor sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — brain tumor Clinical Trials

How many clinical trials are currently recruiting for brain tumor?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for brain tumor, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for brain tumor?

brain tumor research spans Phase 1 (1 trial), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a brain tumor clinical trial?

Eligibility criteria for brain tumor trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 3

Top Sponsors

Georgetown University 1 trial

Cliniques universitaires Saint-Luc- Université Catholique de Louvain 1 trial

InSightec 1 trial

Meyer Children's Hospital IRCCS 1 trial

NaviFUS Corporation 1 trial

Recruiting Clinical Trials

NCT07635329

Recruiting

Home-based Vision Rehabilitation Guided by Brain Imaging

Georgetown University

View Trial →

NCT07323966

Recruiting

Feasibility of Mask-Free Radiotherapy for Brain Tumor Patients

Cliniques universitaires Saint...

View Trial →

NCT05317858 Phase 3

Recruiting

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Enrollment

30 pts

Location

United States, Canad...

MICRO-BRAIN 2024: Study on Pediatric Brain Tumors

Meyer Children's Hospital IRCC...

View Trial →

NCT06496971 Phase 3

Recruiting

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

Brigham and Women's Hospital

View Trial →

NCT04075305

Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Enrollment

8,000 pts

Location

United States, Austr...

Biomarkers of Brain Injury in Children With Brain Tumors

NCT03122197 EARLY_Phase 1

Recruiting

Study of Letrozole in Recurrent Gliomas

University of Cincinnati

View Trial →

NCT05859659

Recruiting

Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)

LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

University of Maryland, Baltim...

View Trial →

NCT04692337

Recruiting

Ommaya Reservoir Placement for Brain Tumor Biomarker Access

Related Conditions

glioma (3) glioblastoma (2) neoplasms (2) visual field defect (1) stroke (1) hemianopia homonymous (1) quadrantanopia (1) cortical blindness (1) visual field defect peripheral (1) visual field loss (1) traumatic brain injury (1) non small cell lung cancer (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology